Articles dans des revues avec comité de lecture (4)
  1. 1. Horckmans, M., Diaz Villamil, E., Verdier, C., Laurell, H., Ruidavets, J.-B., De Roeck, L., Combes, G., Martinez, L. O., & Communi, D. (2022). Loss-of-function N178T variant of the human P2Y4 receptor is associated with decreased severity of coronary artery disease and improved glucose homeostasis. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.1049696
  2. 2. Horckmans, M., Diaz Villamil, E., De Roeck, L., & Communi, D. (2022). Central role of PD-L1 in cardioprotection resulting from P2Y4 nucleotide receptor loss. Frontiers in immunology, 13, 1006934. doi:10.3389/fimmu.2022.1006934
  3. 3. Diaz Villamil, E., De Roeck, L., Vanorle, M., & Communi, D. (2022). UTP regulates the cardioprotective action of transplanted stem cells derived from mouse cardiac adipose tissue. Frontiers in Pharmacology., doi :10.3389/fphar.2022.906173.
  4. 4. Negri, I., Diaz Villamil, E., De Roeck, L., Communi, D., & Horckmans, M. (2019). P2Y2 Nucleotide Receptor Is a Regulator of the Formation of Cardiac Adipose Tissue and Its Fat-Associated Lymphoid Clusters. Stem cells and development, 29(2), Horckmans M and Communi D are equal last authors. doi:10.1089/scd.2019.0200